Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04757584 · ClinicalTrials.gov registry record · Phase 4
Pilot Deprescribing N-of-1 Trials for Beta-blockers in HFpEF
A Phase 4 study, sponsored by Weill Medical College of Cornell University.
- Completed
- Registry status
- Phase 4
- Development phase
- 9
- Enrollment target
NCT04757584 is a Phase 4 study that has completed, run by Weill Medical College of Cornell University. The registered enrollment target is 9 participants.
The verdict
NCT04757584, a Phase 4 study, has completed, sponsored by Weill Medical College of Cornell University.
- COMPLETED
- Registry status
- Phase 4
- Development phase
- 9 participants
- Enrollment target
Study Summary
In this study, we will test the feasibility of N-of-1 trials for deprescribing beta-blockers in patients with Heart Failure with Preserved Ejection Fraction. To achieve this objective we will conduct 16 4-period N-of-1 trials (on vs. off) and subsequently interview participants to better understand feasibility and pragmatism. The N-of-1 trials will be iteratively refined in real-time based on this feedback.
Interventions
- DRUG Beta blockers
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 9 participants |
| Start Date | 2021-04-01 |
| Est. Completion | 2023-04-28 |
| Phase | Phase 4 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT04757584
The ClinicalTrials.gov registry entry for NCT04757584 describes a study currently listed as completed, categorized as Phase 4. The registered enrollment target is 9 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Weill Medical College of Cornell University, which has 701 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Beta blockers is the first listed.
NCT04757584 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT04757584 about?
NCT04757584 is a clinical study titled "Pilot Deprescribing N-of-1 Trials for Beta-blockers in HFpEF". In this study, we will test the feasibility of N-of-1 trials for deprescribing beta-blockers in patients with Heart Failure with Preserved Ejection Fraction. To achieve this objective we will conduct 16 4-period N-of-1 trials (on vs. off) and subsequently interview participants to better understand ...
What is the current status of trial NCT04757584?
This trial is currently completed. It is a Phase 4 study. The enrollment target is 9 participants. The study started on 2021-04-01. Estimated completion is 2023-04-28.
What interventions are being tested in trial NCT04757584?
The interventions under investigation include: Beta blockers (DRUG).
Who is sponsoring clinical trial NCT04757584?
This trial is sponsored by Weill Medical College of Cornell University, which has 701 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.